Autophagy

Autophagy

Pathway Diagram

Overview

Autophagy is a highly conserved cellular degradation pathway through which eukaryotic cells selectively engulf and digest intracellular components, including proteins, lipids, organelles, and protein aggregates. The term derives from Greek words meaning "self-eating." This catabolic process is essential for cellular homeostasis, recycling of cellular material, and maintaining cellular energy balance during nutrient stress. Autophagy represents one of the primary quality control mechanisms in neurons, which are post-mitotic cells particularly vulnerable to accumulation of misfolded proteins and damaged organelles. Three main forms of autophagy exist: macroautophagy, microautophagy, and chaperone-mediated autophagy, with macroautophagy being the most extensively studied and relevant to neurodegeneration[@pmid35435793].

Function/Biology

Autophagy

Pathway Diagram

Overview

Autophagy is a highly conserved cellular degradation pathway through which eukaryotic cells selectively engulf and digest intracellular components, including proteins, lipids, organelles, and protein aggregates. The term derives from Greek words meaning "self-eating." This catabolic process is essential for cellular homeostasis, recycling of cellular material, and maintaining cellular energy balance during nutrient stress. Autophagy represents one of the primary quality control mechanisms in neurons, which are post-mitotic cells particularly vulnerable to accumulation of misfolded proteins and damaged organelles. Three main forms of autophagy exist: macroautophagy, microautophagy, and chaperone-mediated autophagy, with macroautophagy being the most extensively studied and relevant to neurodegeneration[@pmid35435793].

Function/Biology

Macroautophagy initiates with the formation of an isolation membrane, or phagophore, which expands to engulf cytoplasmic cargo and matures into a double-membrane autophagosome. This structure subsequently fuses with lysosomes to form autolysosomes, where hydrolytic enzymes degrade the sequestered material. The resulting degradation products—amino acids, glucose, and fatty acids—are recycled for biosynthesis and energy production through ATP generation.

The autophagy pathway involves over 30 autophagy-related (ATG) proteins, with several key regulators coordinating the process. The mammalian target of rapamycin (mTOR) serves as a master negative regulator, suppressing autophagy during nutrient abundance. Conversely, AMP-activated protein kinase (AMPK) activates autophagy during energy depletion by phosphorylating and inhibiting mTOR. The ULK1/2 kinase complex functions as a primary initiator downstream of mTOR, triggering autophagosome formation. ATG proteins form conjugation systems—notably the ATG12-ATG5 conjugate and the microtubule-associated protein 1A/1B-light chain 3 (LC3) lipidation system—that facilitate membrane curvature and closure of the autophagosome.

Role in Neurodegeneration

Selective autophagy of protein aggregates, termed aggrephagy, is critically impaired across major neurodegenerative diseases. In Alzheimer's disease, amyloid-beta and tau accumulation reflects compromised autophagy, with plaques and tangles representing failed clearance of misfolded proteins. Parkinson's disease neuropathology centers on alpha-synuclein aggregates in Lewy bodies, whose formation and persistence correlate with autophagy dysfunction. Huntington's disease features expansion of polyglutamine tracts in huntingtin protein, whose degradation depends on selective autophagy; mutations impairing this process accelerate disease onset. ALS involves aggregation of superoxide dismutase 1 (SOD1), TDP-43, and FUS proteins, all substrates for autophagic clearance.

Neurons depend uniquely on autophagy due to their extreme cell size, extensive axonal networks, and inability to dilute protein aggregates through cell division. Impaired autophagy leads to accumulation of polyubiquitinated proteins and damaged mitochondria, triggering oxidative stress and neuronal death. Conversely, autophagy enhancement shows neuroprotective effects in multiple disease models, supporting its therapeutic potential.

Molecular Mechanisms

The autophagy machinery recognizes cargo through selective adaptor proteins, including p62/SQSTM1 and NBR1, which contain both ubiquitin-binding domains and LC3-interacting regions. These adaptors target polyubiquitinated substrates to autophagosomes. The E1 ubiquitin-activating enzyme UBE1 and various E3 ligases govern ubiquitination of autophagy substrates. Selective autophagy pathways include mitophagy (mitochondrial autophagy via PINK1/Parkin-mediated ubiquitination) and ER-phagy (endoplasmic reticulum fragments autophagy via FAM134B and other receptors).

Neuroinflammation impairs autophagy through NF-κB signaling, while oxidative stress inactivates ATG proteins through protein modifications. Lysosomal dysfunction—increasingly recognized in neurodegeneration—prevents autophagosome-lysosome fusion and degrades cargo, creating "autophagy flux" impairment detectable by LC3 accumulation and p62 retention.

Clinical/Research Significance

Targeting autophagy represents a major therapeutic strategy in neurodegeneration research. Autophagy enhancers like mTOR inhibitors (rapamycin), AMPK activators (resveratrol, metformin), and ATG inducers (trehalose, spermidine) demonstrate disease-modifying potential in preclinical models. Understanding autophagy dysfunction guides development of therapeutics, with several compounds in clinical trials for neurodegenerative diseases.

Related Entities

• Proteasomal degradation
• Unfolded protein response (UPR)
• Mitophagy and selective autophagy

• Pathway Diagram